Company: MCGAU
Filing Date: 2025-08-26
Form Type: 425
Source: 0001104659-25-083156
Chunk: 14

Company: Yorkville Acquisition Corp.
Filing Date: 2025-08-26
Form: 425
Chunk 14
---
 or inaccuracy is incapable of being cured or is not cured within the earlier of (A) 20 days after written notice of such breach
or inaccuracy is provided to the Company by the Sellers or (B) five Business Days prior to the Outside Date; (v) by written
notice by Crypto.com or TMTG to the other Parties if there has been a Modification in Recommendation; (vi) by written notice by the
Company to the Sellers, if (a) there has been a material breach by either Seller of any of their respective representations, warranties,
covenants or agreements contained in the Business Combination Agreement, or if any representation or warranty of such Parties shall have
become materially untrue or materially inaccurate, in any case, which would result in a failure of a condition as set forth in the Business
Combination Agreement to be satisfied (treating the Closing Date for such purposes as the date of the Business Combination Agreement or,
if later, the date of such breach), and (b) the breach or inaccuracy is incapable of being cured or is not cured within the earlier
of (A) 20 days after written notice of such breach or inaccuracy is provided to the Sellers by SPAC or (B) five Business Days
prior to the Outside Date; and (vii) without prejudice to the Company’s obligations under the Business Combination Agreement,
by written notice by either the Company or the Sellers to the others if the Extraordinary General Meeting is held (including any adjournment
or postponement thereof) and has concluded, the Company’s Shareholders have duly voted, and the Required Shareholder Approval was
not obtained.

Sponsor Support Agreement

The Parties have entered into the Sponsor Support
Agreement (the “Sponsor Support Agreement”), pursuant to which the Sponsor has agreed, among other things, to
vote in favor of each Shareholder Approval Matter, against any Acquisition Proposal or Alternative Transaction (each as defined in the
Sponsor Support Agreement), against any merger, consolidation, combination, sale of substantial assets, reorganization, recapitalization,
dissolution, liquidation or winding up of or by the Company (other than the Transactions), against any change in the business of the Company;
and against any proposal, action or agreement involving the Company that would or would reasonably be expected to (i) impede, frustrate,
prevent or nullify any provision of the Sponsor Support Agreement, the Business Combination Agreement or any ancillary document, (ii) result
in a breach